Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2

[1] Msemburi W(2023)The WHO estimates of excess mortality associated with the COVID-19 pandemic Nature 613 130-7

[2] Karlinsky A(2020)Mechanisms of SARS-CoV-2 transmission and pathogenesis Trends Immunol 41 1100-15

[3] Knutson V(2023)Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic J Med Virol 95 e28231-45

[4] Aleshin-Guendel S(2022)Association of comorbidities with the COVID-19 severity and hospitalization: a study among the recovered individuals in Bangladesh Int J Health Sci 16 30-e23

[5] Chatterji S(2022)Prevalence of comorbidities and symptoms stratified by severity of illness amongst adult patients with COVID-19: a systematic review Arch Med Sci Atheroscler Dis 7 e5-96

[6] Wakefield J(2021)Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat J Virol 95 e0086121-67

[7] Harrison AG(2021)Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial EClinicalMedicine 35 100849-9

[8] Lin T(2022)Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture Commun Biol 5 958-9

[9] Wang P(2022)Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19 Eur J Epidemiol 37 789-27

[10] Horita N(2022)Paxlovid: mechanism of action, synthesis, and in silico study BioMed Res Int 2022 7341493-50

[1] Msemburi W(2023)The WHO estimates of excess mortality associated with the COVID-19 pandemic Nature 613 130-7

[2] Karlinsky A(2020)Mechanisms of SARS-CoV-2 transmission and pathogenesis Trends Immunol 41 1100-15

[3] Knutson V(2023)Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic J Med Virol 95 e28231-45

[4] Aleshin-Guendel S(2022)Association of comorbidities with the COVID-19 severity and hospitalization: a study among the recovered individuals in Bangladesh Int J Health Sci 16 30-e23

[5] Chatterji S(2022)Prevalence of comorbidities and symptoms stratified by severity of illness amongst adult patients with COVID-19: a systematic review Arch Med Sci Atheroscler Dis 7 e5-96

[6] Wakefield J(2021)Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat J Virol 95 e0086121-67

[7] Harrison AG(2021)Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial EClinicalMedicine 35 100849-9

[8] Lin T(2022)Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture Commun Biol 5 958-9

[9] Wang P(2022)Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19 Eur J Epidemiol 37 789-27

[10] Horita N(2022)Paxlovid: mechanism of action, synthesis, and in silico study BioMed Res Int 2022 7341493-50